Skip to main content
Premium Trial:

Request an Annual Quote

Evotec Acquires iPSC Drug-Discovery Assets From Ncardia

NEW YORK – Evotec said today that it has acquired certain assets from Ncardia related to the use of induced pluripotent stem cells for drug discovery.

The assets include intellectual property relevant to iPSC-based phenotypic drug discovery and an existing undisclosed product business around iPSC-derived cells. Evotec said it is also taking on 17 stem cell biology experts operating out of laboratories at the BioCampus Cologne in Germany.

The Cologne-based team's expertise is in generating multiple disease-relevant cell types from iPSCs and applying them in drug discovery. Evotec said that combining this with its own iPSC expertise and drug-discovery platforms will create new biological research opportunities and enhance new and existing partnerships.

"Additional expertise and capacity in the iPSC space as well as a substantial partner network will allow us to further accelerate our efforts to build a world-leading iPSC translational biology platform across different disease areas," Evotec CSO Cord Dohrmann said in a statement.

Financial details of the transaction were not disclosed.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.